Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 3 at ACC.24 including TARGET BP I (0:39), DEDICATE DZHK6 (3:07) and FULL REVASC (6:31).
ACC.org will provide coverage of all the late-breaking science being presented at ACC.24 (accscientifics...) to help you find out how it all fits into your practice. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page (www.acc.org/La.... Follow the ACC on Social Media (www.acc.org/Ab...) and use the hashtag #ACC24 ( / acc24 ) to join the conversation.